Author
Listed:
- GiNell Elliott
(Center for Genome Sciences and Systems Biology, Washington University School of Medicine)
- Chibo Hong
(Brain Tumor Research Center, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco)
- Xiaoyun Xing
(Center for Genome Sciences and Systems Biology, Washington University School of Medicine)
- Xin Zhou
(Center for Genome Sciences and Systems Biology, Washington University School of Medicine)
- Daofeng Li
(Center for Genome Sciences and Systems Biology, Washington University School of Medicine)
- Cristian Coarfa
(Baylor College of Medicine)
- Robert J.A. Bell
(Brain Tumor Research Center, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
Institute for Human Genetics, University of California San Francisco,)
- Cecile L. Maire
(Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute)
- Keith L. Ligon
(Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute)
- Mahvash Sigaroudinia
(Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco)
- Philippe Gascard
(Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco)
- Thea D. Tlsty
(Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco)
- R. Alan Harris
(Baylor College of Medicine)
- Leonard C. Schalkwyk
(School of Biological Sciences, University of Essex)
- Misha Bilenky
(Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency)
- Jonathan Mill
(Social Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London
University of Exeter Medical School, Exeter University, St Luke's Campus)
- Peggy J. Farnham
(University of California-Davis)
- Manolis Kellis
(The Broad Institute of MIT and Harvard)
- Marco A. Marra
(Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency)
- Aleksandar Milosavljevic
(Baylor College of Medicine)
- Martin Hirst
(Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency
University of British Columbia)
- Gary D. Stormo
(Center for Genome Sciences and Systems Biology, Washington University School of Medicine)
- Ting Wang
(Center for Genome Sciences and Systems Biology, Washington University School of Medicine)
- Joseph F. Costello
(Brain Tumor Research Center, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco)
Abstract
The role of intermediate methylation states in DNA is unclear. Here, to comprehensively identify regions of intermediate methylation and their quantitative relationship with gene activity, we apply integrative and comparative epigenomics to 25 human primary cell and tissue samples. We report 18,452 intermediate methylation regions located near 36% of genes and enriched at enhancers, exons and DNase I hypersensitivity sites. Intermediate methylation regions average 57% methylation, are predominantly allele-independent and are conserved across individuals and between mouse and human, suggesting a conserved function. These regions have an intermediate level of active chromatin marks and their associated genes have intermediate transcriptional activity. Exonic intermediate methylation correlates with exon inclusion at a level between that of fully methylated and unmethylated exons, highlighting gene context-dependent functions. We conclude that intermediate DNA methylation is a conserved signature of gene regulation and exon usage.
Suggested Citation
GiNell Elliott & Chibo Hong & Xiaoyun Xing & Xin Zhou & Daofeng Li & Cristian Coarfa & Robert J.A. Bell & Cecile L. Maire & Keith L. Ligon & Mahvash Sigaroudinia & Philippe Gascard & Thea D. Tlsty & R, 2015.
"Intermediate DNA methylation is a conserved signature of genome regulation,"
Nature Communications, Nature, vol. 6(1), pages 1-10, May.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7363
DOI: 10.1038/ncomms7363
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7363. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.